Convalescent plasma therapy and long-term SARS-COV-2 antiviral immune response in a prospective cohort of patients with COVID-19.
Barrera A, Martínez-Valdebenito C, Nervi B, Gaete-Argel A, Gálvez NMS, Osses C, Vizcaya C, Ceballos ME, Pereira J, Chang M, Rojas L, Mondaca S, Henríquez C, Kalergis AM, Sette A, Grifoni A, Soto-Rifo R, Valiente-Echeverría F, Ferres M, Balcells ME, Corre NL.
Barrera A, et al.
Curr Res Microb Sci. 2025 Jul 9;9:100440. doi: 10.1016/j.crmicr.2025.100440. eCollection 2025.
Curr Res Microb Sci. 2025.
PMID: 40740192
Free PMC article.